2,375
Views
84
CrossRef citations to date
0
Altmetric
Original Research Articles

Case–control study of breast cancer and exposure to synthetic environmental chemicals among Alaska Native women

, , , , , , , & show all
Article: 25760 | Received 18 Aug 2014, Accepted 08 Oct 2014, Published online: 13 Nov 2014

References

  • Day G, Holck P, Provost EM. Alaska Native mortality update: 2004–2008. 2011; Anchorage, AK: Alaska Native Epidemiology Center. 362. Supported by the Alaska Native Tribal Health Consortium.
  • Kelly JJ, Schade TL, Starkey BM, White S, Ashokkumar R, Lanier AP. Cancer in Alaska Native people 40-year report, 1969–2008. 2012; Anchorage, AK: Office of Alaska Native Health Research, Alaska Native Epidemiology Center. 136. Supported by the Alaska Native Tribal Health Consortium.
  • Damstra T, Barlow S, Bergman A, Kavlock R, Van Der Kraak G. Global assessment of the state-of-the-science of endocrine disruptors. 2002; Geneva: International Programme on Chemical Safety, World Health Organization.
  • Rubin CH, Lanier AP, Kieszak S, Brock JW, Koller KR, Strosnider H, etal. Breast cancer among Alaska Native women potentially exposed to environmental organochlorine chemicals. Int J Circumpolar Health. 2006; 65: 18–27.
  • López-Cervantes M, Torres-Sánchez L, Tobías A, López-Carrillo L. Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiologic evidence. Environ Health Perspect. 2004; 112: 207–14.
  • Snedeker S. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect. 2001; 109(Suppl. 1): 35–41.
  • Dewailly E, Dodin S, Verreault R, Ayotte P, Sauvé L, Morin J, etal. High organochlorine body burden in women with oestrogen receptor-positive breast cancer. J Natl Cancer Inst. 1994; 86: 232–4.
  • Falck FY, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992; 47: 143–6.
  • Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993; 85: 648–52.
  • Gammon MD, John EM. Recent etiologic hypotheses concerning breast cancer. Epidemiol Rev. 1993; 15: 163–8.
  • Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, etal. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8: 525–32.
  • Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994; 86: 589–99.
  • Laden F, Hunter DJ. Environmental risk factors and female breast cancer. Ann Rev Public Health. 1998; 19: 101–23.
  • Laden F, Hankinson SE, Wolff MS, Colditz GA, Willett WC, Speizer FE, etal. Plasma organochlorine levels and the risk of breast cancer: a continued follow-up. Int J Cancer. 2001; 91: 568–74.
  • Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, etal. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med. 1997; 337: 1253–8.
  • Pavuk M, Cerhan JR, Lynch CF, Kocan A, Petrik J, Chovancova J. Case-control study of PCBs, other organochlorines and breast cancer in Eastern Slovakia. J Expo Anal Environ Epidemiol. 2003; 13: 267–75.
  • Ceccatelli R, Faass O, Schlumpf M, Lichtensteiger W. Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenyl ether PBDE 99 and PCB. Toxicology. 2006; 220: 104–16.
  • Stoker TE, Cooper RL, Lambright CS, Wilson VS, Furr J, Gray LE. In vivo and in vitro anti–androgenic effects of DE–71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicol Appl Pharmacol. 2005; 207: 78–88.
  • Talsness CE, Shakibaei M, Kuriyama SN, Grande SW, Sterner-Kock A, Schnitker P, etal. Ultrastructural changes observed in rat ovaries following in utero and lactational exposure to low doses of a polybrominated flame retardant. Toxicol Lett. 2005; 157: 189–202.
  • Legler J, Brouwer A. Are brominated flame retardants endocrine disruptors?. Environ Int. 2003; 29: 879–85.
  • Hurley S, Reynolds P, Goldberg D, Nelson DO, Jeffrey SS, Petreus M. Adipose levels of polybrominated diphenyl ethers and risk of breast cancer. Breast Cancer Res Treat. 2011; 129: 505–11.
  • Department of Health and Human Services. Centers for Disease Control and Prevention. Fourth national report on human exposure to environmental chemicals.
  • López-Carrillo L , Hernández-Ramírez RU , Calafat AM , Torres-Sánchez L , Galván-Portillo M , Needham LL , etal. Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect. 2010; 118: 539–44.
  • Nobmann ED, Byers T, Lanier AP, Hankin JH, Jackson MY. The diet of Alaska Native adults: 1987–1988. Am J Clin Nutr. 1992; 55: 1024–32.
  • Rubin CH, Lanier A, Socha M, Brock JW, Kieszak S, Zahm S. Exposure to persistent organochlorines among Alaska Native women. Int J Circumpolar Health. 2001; 60: 157–69.
  • Arctic Monitoring and Assessment Programme (AMAP). Transport of contaminants to the Arctic and their fate [fact sheet]. 2002; Oslo, Norway: AMAP.
  • Department of Health and Human Services. Public Health Service, Agency for Toxic Substance and Disease Registry (US). Toxicological profile for polybrominated biphenyls and polybrominated diphenyl ethers.
  • Wittassek M , Koch HM , Angerer J , Brüning T . Assessing exposure to phthalates – the human biomonitoring approach. Mol Nutr Food Res. 2011; 55: 7–31.
  • Sjödin A, Jones RS, Lapeza CR, Focant JF, McGahee EE 3rd , Patterson DG Jr. . Semiautomated high–throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem. 2004; 76: 1921–7.
  • Silva MJ, Malek NA, Hodge CC, Reidy JA, Kato K, Barr DB, etal. Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 789: 393–404.
  • Hornung RW, Reed LD. Estimation of average concentration in the presence of non-detectable values. Appl Occup Environ Hyg. 1990; 5: 46–51.
  • Day GE, Lanier AP, Bulkow L, Kelly JJ, Murphy N. Cancers of the breast, uterus, ovary and cervix among Alaska Native women, 1974–2003. Int J Circumpolar Health. 2010; 69: 72–86.
  • Petreas M, She J, Brown FR, Winkler J, Windham G, Rogers E, etal. High body burdens of 2,2′,4,4′–tetrabromodiphenyl ether (BDE-47) in California women. Environ Health Perspect. 2003; 111: 1175–9.
  • Schecter A, Päpke O, Tung KC, Joseph J, Harris TR, Dahlgren J. Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls. J Occup Environ Med. 2005; 47: 199–211.
  • Meeker JD, Calafat AM, Hauser R. Urinary phthalate metabolites and their biotransformation products: predictors and temporal variability among men and women. J Exp Sci Environ Epidemiol. 2012; 22: 376–85.
  • Buteau–Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot–Applanat M. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J Endocrinol. 2008; 196: 399–412.
  • Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, etal. Phthalates induce proliferation and invasiveness of estrogen receptor–negative breast cancer through the AhR/hdAC6/c-Myc signaling pathway. FASEB J. 2012; 26: 778–87.
  • Meeker JD, Sathyanarayana S, Swan SH. Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans R Soc Lond B Biol Sci. 2009; 364: 2097–113.
  • Gray J, Nudelman MA, Engel C. State of the evidence: the connection between breast cancer and the environment. 2010; San Francisco, CA: Breast Cancer Fund. 127.
  • De los Santos JF, Buchholz TA. Carcinoma of the male breast. Curr Treat Options Oncol. 2000; 1: 221–7.
  • Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1558–68.
  • Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol. 2009; 169: 1251–9.
  • Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9: R6.
  • St-Hilaire S, Mandal R, Commendador A, Mannel S, Derryberry D. Estrogen receptor positive breast cancers and their association with environmental factors. Int J Health Geogr. 2011; 10: 32.
  • Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011; 103: 250–63.
  • Høyer AP, Jørgensen T, Rank F, Grandjean P. Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer. 2001; 1: 8.